title: Adenosine receptor blockade enhances myocardial stunning without a sustained effect on fluorine-18-FDG uptake postreperfusion.
abstract: The aim of this study was to determine whether adenosine receptor blockade before ischemia would enhance the degree of stunning and induce a sustained decrease in glucose uptake after reperfusion.
  
  
  METHODS
  Stunning was induced in 14 anesthetized swine by partially occluding the left anterior descending artery (LAD) for 20 min (> 80% flow reduction). Seven animals were pretreated with the nonspecific adenosine receptor blocker 8-phenyltheophylline (8-PT; 5 mg/kg), which decreased reactive hyperemia by an average of 38%. Myocardial glucose uptake was assessed 1 hr following reperfusion with PET and the glucose analog 18F-fluorodeoxyglucose (FDG).
  
  
  RESULTS
  Before ischemia, systolic shortening in the LAD region was 15% +/- 6% in the control group and 16% +/- 4% in the 8-PT group and in both groups was reduced to - 1% +/- 2% during ischemia. After reperfusion, systolic shortening was 7% +/- 3% in the control group and 2% +/- 3% in the 8-PT group (p < 0.05). Myocardial oxygen consumption before ischemia was 4.58 +/- 3.03 micromol/min/g in the control group and 4.44 +/- 1.83 micromol/min/g in the 8-PT group (ns) and neither were different after reperfusion. In the postischemic LAD region, myocardial glucose uptake was 0.18 +/- 0.15 micromol/min/g in the control group and was similar to that of the 8-PT group (0.17 +/- 0.08 micromol/min/g; ns).
  
  
  CONCLUSIONS
  The nonspecific adenosine blocker 8-PT enhanced the degree of stunning when given before ischemia but did not induce a sustained effect on myocardial glucose uptake after reperfusion.
authors.affiliation: Division of Cardiology, VA Medical Center, University of Minnesota, Minneapolis 55417, USA.
authors.forename: E O
authors.initials: EO
authors.lastname: McFalls
authors.forename: D
authors.initials: D
authors.lastname: Baldwin
authors.forename: D
authors.initials: D
authors.lastname: Marx
authors.forename: D
authors.initials: D
authors.lastname: Jaimes
authors.forename: P
authors.initials: P
authors.lastname: Fashingbauer
authors.forename: H B
authors.initials: HB
authors.lastname: Ward
mesh_terms: D000818:Animals; D003326:Coronary Circulation; D019788:Fluorodeoxyglucose F18; D005947:Glucose / Q000378:metabolism; D006439:Hemodynamics; D019344:Lactic Acid / Q000378:metabolism; D009200:Myocardial Contraction; D015425:Myocardial Reperfusion; D017682:Myocardial Stunning / Q000000981:diagnostic imaging* / Q000503:physiopathology*; D009206:Myocardium / Q000378:metabolism; D010101:Oxygen Consumption; D058915:Purinergic P1 Receptor Antagonists; D013552:Swine; D013806:Theophylline / Q000031:analogs & derivatives / Q000494:pharmacology; D014055:Tomography, Emission-Computed
chemical_list: D058915:Purinergic P1 Receptor Antagonists; D019788:Fluorodeoxyglucose F18; D019344:Lactic Acid; D013806:Theophylline; C028322:8-phenyltheophylline; D005947:Glucose